Associate Director of Administration
Hollings Cancer Center, Medical University of South Carolina
The Opportunity: In collaboration with the HCC Director and the faculty and staff of the Medical University of South Carolina (MUSC), the HCC Associate Director of Administration works to ensure continued development of the HCC. He/She provides executive assistance to the HCC Director to plan and implement program and financial goals to maintain NCI cancer center designation and support the growth of the center.
The Ideal Candidate: The ideal candidate will be a seasoned healthcare professional with strong business acumen and interpersonal skills who can lead ongoing growth efforts within HCC and serve as an advisor to the Director of the Center. Preferred candidates will have been through at least one full CCSG submission renewal cycle and preferably, have experience in preparing the application for comprehensive status. A Master’s degree in business, finance or health administration from an accredited institution is required; a PhD is desirable but not mandatory. The qualified candidate will have a minimum of five years experience in research administration within a multidisciplinary health care or academic medical setting. Experience with NIH and other grants management required, as is demonstrated experience in financial management of a department or center. He/she must have ability to plan and manage competing priorities in multiple programs and projects and in fiscal and facility operations.
Hollings Cancer Center
is recognized by U.S. News & World Report as being among the top 25% of cancer programs in the nation and is one of fewer than 70 National Cancer Institute– designated cancer centers. As one of the leading cancer treatment centers in the Southeast, the HCC combines the full range of cancer specialties, including medical oncology, radiation oncology, and numerous surgical oncology subspecialties. Its multidisciplinary tumor boards enable physicians to share their collective expertise to explore the best treatments for individual patients. Physicians at the HCC also have daily interactions with more than 100 cancer scientists who are actively examining the genetics of cancer, mechanisms of cancer initiation and progression, developing new target cancer therapies and vaccines, and identifying new effective cancer prevention and control strategies. The HCC has been successful in renewing its Cancer Center Support Grant (CCSG) in 2014, with a sustained positive growth trajectory in scientific expertise, research and statewide impact.
Send CV, nominations or referrals, to: Alan Johns
, Academic Medicine & Health Sciences Division, Tyler & Company